These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26136431)

  • 1. The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors.
    Chevaleyre C; Benhamouda N; Favry E; Fabre E; Mhoumadi A; Nozach H; Marcon E; Cosler G; Vinatier E; Oudard S; Hans S; Le Pimpec-Barthes F; Bats AS; Castelli FA; Tartour E; Maillère B
    J Immunol; 2015 Aug; 195(4):1891-901. PubMed ID: 26136431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
    Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
    Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchy of CD4 T cell epitopes of the ANRS Lipo5 synthetic vaccine relies on the frequencies of pre-existing peptide-specific T cells in healthy donors.
    Castelli FA; Szely N; Olivain A; Casartelli N; Grygar C; Schneider A; Besse A; Levy Y; Schwartz O; Maillère B
    J Immunol; 2013 Jun; 190(11):5757-63. PubMed ID: 23636059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.
    Campi G; Crosti M; Consogno G; Facchinetti V; Conti-Fine BM; Longhi R; Casorati G; Dellabona P; Protti MP
    Cancer Res; 2003 Dec; 63(23):8481-6. PubMed ID: 14679013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
    Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
    Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
    Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
    Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses.
    Brown WC; McGuire TC; Zhu D; Lewin HA; Sosnow J; Palmer GH
    J Immunol; 2001 Jan; 166(2):1114-24. PubMed ID: 11145692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
    J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
    Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer.
    Dhiman G; Lohia N; Jain S; Baranwal M
    Microbiol Immunol; 2016 Sep; 60(9):646-52. PubMed ID: 27554419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
    Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
    J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mycobacterial peptide epitopes recognized by CD4+ T cells in association with multiple major histocompatibility complex class II molecules.
    Mustafa AS
    Nutrition; 1995; 11(5 Suppl):657-60. PubMed ID: 8748245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.
    Ayyoub M; Souleimanian NE; Godefroy E; Scotto L; Hesdorffer CS; Old LJ; Valmori D
    Clin Immunol; 2006; 118(2-3):188-94. PubMed ID: 16368270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients.
    Mizote Y; Taniguchi T; Tanaka K; Isobe M; Wada H; Saika T; Kita S; Koide Y; Uenaka A; Nakayama E
    Vaccine; 2010 Jul; 28(32):5338-46. PubMed ID: 20665979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles.
    Godefroy E; Scotto L; Souleimanian NE; Ritter G; Old LJ; Jotereau F; Valmori D; Ayyoub M
    Clin Immunol; 2006 Oct; 121(1):54-62. PubMed ID: 16814609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
    Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
    Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus-1 reverse transcriptase immunodominant CD4+ T cell epitopes: a peptide-based multiparametric assessment in the mouse.
    Borg JP; Ihlenfeldt HG; Jung G; Haas G; Pierres M
    Eur J Immunol; 1994 Jul; 24(7):1496-502. PubMed ID: 7517871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with the RTS,S/AS malaria vaccine induces IFN-γ(+)CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge.
    Schwenk R; Lumsden JM; Rein LE; Juompan L; Kester KE; Heppner DG; Krzych U
    Vaccine; 2011 Nov; 29(48):8847-54. PubMed ID: 21983360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes.
    Schulze zur Wiesch J; Lauer GM; Day CL; Kim AY; Ouchi K; Duncan JE; Wurcel AG; Timm J; Jones AM; Mothe B; Allen TM; McGovern B; Lewis-Ximenez L; Sidney J; Sette A; Chung RT; Walker BD
    J Immunol; 2005 Sep; 175(6):3603-13. PubMed ID: 16148104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of HLA-DR- and HLA-DP4-restricted CD4+ T cell response specific for the tumor-shared antigen survivin in healthy donors and cancer patients.
    Wang XF; Kerzerho J; Adotevi O; Nuyttens H; Badoual C; Munier G; Oudard S; Tu S; Tartour E; Maillère B
    J Immunol; 2008 Jul; 181(1):431-9. PubMed ID: 18566409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.